Meglumine antimoniate.

DRUG2 trials

Sponsors

Hospital Universitário Professor Edgard Santos, Universidad de Antioquia

Conditions

Leishmaniasis, CutaneousTreatment of Cutaneous Leishmaniasis in Brazil.

Phase 2

Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)

CompletedNCT00600548

Hospital Universitário Professor Edgard SantosTreatment of Cutaneous Leishmaniasis in Brazil.

Start: 2007-07-31End: 2009-07-31Updated: 2010-04-15

Phase 3

Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.

RecruitingNCT06822478

Universidad de AntioquiaLeishmaniasis, Cutaneous

Start: 2026-03-11End: 2030-02-01Target: 96Updated: 2026-04-02

Related Papers

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.

2010-12-21154 citations